A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia

Atherosclerosis

Volumn 198, Issue 1, 2008, Pages 145-151

  Pisciotta, Livia ^a   Fasano, Tommaso ^b   Calabresi, Laura ^c   Bellocchio, Antonella ^a   Fresa, Raffaele ^a   Borrini, Claudia ^a   Calandra, Sebastiano ^b   Bertolini, Stefano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

APOA1 gene mutation; Cardiovascular disease; Familial combined hyperlipidemia; HDL deficiency

Indexed keywords

APOLIPOPROTEIN A1; CYTOSINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; APOA1 GENE; ARTERY MEDIA; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; ECHOGRAPHY; EXON; FAMILIAL COMBINED HYPERLIPIDEMIA; FAMILIAL HYPERLIPEMIA; FIBROMUSCULAR DYSPLASIA; FRAMESHIFT MUTATION; GENE; GENE INSERTION; GENE MUTATION; HETEROZYGOTE; HUMAN; INTIMA; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOKING; STOP CODON; THICKNESS;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CAROTID ARTERY DISEASES; CHOLESTEROL, HDL; CODON, NONSENSE; ESTERIFICATION; FAMILY HEALTH; FEMALE; FRAMESHIFT MUTATION; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPIDS; MALE; MIDDLE AGED; PEDIGREE; RECEPTORS, LDL; SERINE ENDOPEPTIDASES; SMOKING;

EID: 40949089734     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.017     Document Type: Article

References (37)

1. Schaefer J.R., Rader D.J., Ikewaki K., et al. In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemia. Arterioscler Thromb 12 (1992) 843-848
2. Frenais R., Ouguerram K., Maugeais C., et al. Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study. J Lipid Res 40 (1999) 1506-1511
3. Guerin M., Dolphin P.J., and Chapman M.J. Preferential cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia. Arterioscler Thromb 14 (1994) 679-685
4. Guerin M., Dolphin P.J., Talussot C., et al. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 15 (1995) 1359-1368
5. Lamarche B., Rashid S., and Lewis G.F. HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 286 (1999) 145-161
6. Veerkamp M.J., de Graaf J., Hendriks J.C., Demacker P.N., and Stalenhoef A.F. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation 109 (2004) 2980-2985
7. Rashid S., Barrett P.H., Uffelman K.D., et al. Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation. Arterioscler Thromb Vasc Biol 22 (2002) 483-487
8. Soro A., Jauhiainen M., Ehnholm C., and Taskinen M.-R. Determinants of low HDL levels in familial combined hyperlipidemia. J Lipid Res 44 (2003) 1536-1544
9. van der Vleuten G.M., van Tits L.J.H., den Heijer M., et al. Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile. J Lipid Res 46 (2005) 2398-2404
10. Pisciotta L., Miccoli R., Cantafora A., et al. Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. Atherosclerosis 167 (2003) 335-345
11. Hovingh G.K., Brownlie A., Bisoendial R.J., et al. A novel ApoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J Am Coll Cardiol 44 (2004) 1429-1435
12. Ikewaki K., Matsunaga A., Han H., et al. A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease. Atherosclerosis 172 (2004) 39-45
13. E136X) cause low HDL cholesterol in French Canadians. Atherosclerosis 185 (2006) 127-136
14. Kiss R.S., Kavaslar N., Okuhira K.-I., et al. Genetic etiology of isolated low HDL syndrome. Incidence and heterogeneity of effux defects. Arterioscler Thromb Vasc Biol 27 (2007) 1139-1145
15. Calabresi L., Pisciotta L., Costantin A., et al. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes. A comprehensive study of molecular and biochemical finding in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25 (2005) 1972-1978
16. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
17. Moriyama K., Sasaki J., Takata Y., et al. A cysteine-containing truncated Apo A-I variant associated with HDL deficiency. Arterioscler Thromb Vasc Biol 16 (1996) 1416-1423
18. Pisciotta L., Priore Oliva C., Baldassare Cefalù A., et al. Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia. Atherosclerosis 186 (2006) 433-440
19. Priore Oliva C., Pisciotta L., Li Volti G., et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol 25 (2005) 411-417
20. Hopkins P.N., Heiss G., Ellison C., et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia. Circulation 108 (2003) 519-523
21. Mar R., Pajukanta P., Allayee H., et al. Association of Apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ Res 94 (2004) 993-999
22. van der Vleuten G.M., Isaacs A., Zeng W.-W., et al. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia. Biochim Biophys Acta 1772 (2007) 81-88
23. Pennacchio L.A., Olivier M., Hubacek J.A., et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11 (2002) 3031-3038
24. Talmud P.J., Hawe E., Martin S., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11 (2002) 3039-3046
25. Lai C.-Q., Demissie S., Cupples L.A., et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 45 (2004) 2096-2105
26. Sviridov D., and Nestel P.J. Genetic factors affecting HDL levels, structure, metabolism and function. Curr Opin Lipidol 18 (2007) 157-163
27. MALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia. J Lipid Res 43 (2002) 115-123
28. Lackner K.J., Dieplinger H., Nowicka G., and Schimtz G. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene. J Clin Invest 92 (1993) 2262-2273
29. Römling R., von Eckardstein A., Funke H., et al. A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas. Arterioscler Thromb 14 (1994) 1915-1922
30. Takata K., Saku K., Ohta T., et al. A new case of ApoA-I deficiency showing codon 8 nonsense mutation of the ApoA-I gene without evidence of coronary heart disease. Arterioscler Thromb Vasc Biol 15 (1995) 1866-1874
31. Ng D.S., Vezina C., Wolever T.S., et al. Apolipoprotein A-I deficiency. Biochemical and metabolic characteristics. Arterioscler Thromb Vasc Biol 15 (1995) 2157-2164
32. Fin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene. Arterioscler Thromb Vasc Biol 17 (1997) 83-90
33. Zaragoza (L144R). Atherosclerosis 154 (2001) 613-623
34. Heath K.E., Whittall R.A., Miller G.J., and Humphries S.E. I705 variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levels. J Med Genet 37 (2000) 713-715
35. Alharbi K.K., Aldahmesh M.A., Spanakis E., et al. Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population. Genome Res 15 (2005) 967-977
36. Pisciotta L., Hamilton-Craig I., Tarugi P., et al. Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. Atherosclerosis 172 (2004) 309-320
37. Pisciotta L., Calabresi L., Lupattelli G., et al. Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes. Atherosclerosis 182 (2005) 153-159